The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
To implement AI-enabled chest X-ray solution for TB & COVID-19 screening in Maharashtra through Unitaid funding
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
Sets price band at ?695 to ?735 per Equity Share
Robots make it to the healthcare conference panel, reflecting the future potential of technology
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Subscribe To Our Newsletter & Stay Updated
